FDA Approved: SORAFENIB — Original Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Teva's original application for a generic sorafenib product, enabling a generic version of the cancer drug Sorafenib to be marketed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Carcinoma
• Hepatocellular Carcinoma
• Renal Cell Carcinoma

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

ORIG AP for SORAFENIB (SORAFENIB)